Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

NCT03642340 is registered in ClinicalTrials.gov with IlDong Pharmaceutical Co Ltd as lead sponsor.

NCT NCT03642340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo
Lead sponsor
IlDong Pharmaceutical Co Ltd
Phase
Observational
Overall status
Unknown status
Start date
May 15, 2017
Completion date
August 15, 2023
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b